Robert Bryan Barriger
26 works · 1,932 citations · h-index 11
Top works
- Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
- A Dose–Volume Analysis of Radiation Pneumonitis in Non–Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
- Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer
- Predicting Esophagitis After Chemoradiation Therapy for Non-Small Cell Lung Cancer: An Individual Patient Data Meta-Analysis
- No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early- Stage Peripheral Non-Small Cell Lung Cancer: An Analysis of RTOG 0236
- Dose–Volume Analysis of Radiation Pneumonitis in Non–Small-Cell Lung Cancer Patients Treated With Concurrent Cisplatinum and Etoposide With or Without Consolidation Docetaxel
- Matched‐pair and propensity score comparisons of outcomes of patients with clinical stage I non–small cell lung cancer treated with resection or stereotactic radiosurgery
- Chest Wall Toxicity After Stereotactic Body Radiotherapy for Malignant Lesions of the Lung and Liver
- ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.
- Phosphorus-32 therapy for cystic craniopharyngiomas
- Maximum Dose to Chest Wall Greater than 60 Gy and Volume of Chest Wall Receiving Greater than 30 Gy Predict Risk of Chest Wall Toxicity following Stereotactic Body Radiation Therapy (SBRT)
- No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236
- ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer
- Rates and Risk of Pneumonitis in Non-small Cell Lung Carcinoma (NSCLC) Patients (pts) Treated with Concurrent Chemoradiation
- Treatment of anal carcinoma in immune-compromised patients
- Predicting Symptomatic Radiation Pneumonitis After Concurrent Chemoradiation Therapy for Non-small Cell Lung Cancer: Results of an International Individual Patient Data Meta-analysis
- Predicting Radiation Pneumonitis after Chemoradiotherapy for Lung Cancer: An International Individual Patient Data Meta-analysis
- A Dosimetric Analysis of Radiation Pneumonitis in Non–small-cell Lung Cancer Patients Treated with Stereotactic Body Radiotherapy
- Chest wall toxicities: prediction and management
- INDUCTION AND ADJUVANT THERAPY FOR N2 NON-SMALL-CELL LUNG CANCER